SL Science Holding Ltd
SL Science Holding develops cellular and gene therapies using gamma delta T cells to target solid tumors, including pancreatic and brain cancers.
6-KSep 24Latest SEC filing, period to Sep 24
Jul 10Latest story
July 2026
Sign in